These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 4455039)

  • 1. Investigations on the activity of lactic dehydrogenase and its inhibitors in the serum of uremic patients during hemodialysis.
    Lutz W; Markiewicz K; Klyszejkostefanowicz L
    Acta Med Pol; 1974; 15(3):97-104. PubMed ID: 4455039
    [No Abstract]   [Full Text] [Related]  

  • 2. Nature of the inhibitors of lactate dehydrogenase in uremic dialysates.
    Wilkinson JH; Fujimoto Y; Senesky D; Ludwig GD
    J Lab Clin Med; 1970 Jan; 75(1):109-19. PubMed ID: 4378401
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of liver function in patients with chronic hemodialysis treatment].
    Zazgornik J; Schmidt P; Kopsa H; Kotzaurek R
    Wien Klin Wochenschr; 1972 Dec; 84(52):838-41. PubMed ID: 4651911
    [No Abstract]   [Full Text] [Related]  

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum lactic dehydrogenase activity and lactic dehydrogenase isoenzymes pattern in oral cancer patients--a diagnostic aid.
    Jina RP; Jina R; Rai SP
    Uttar Pradesh State Dent J; 1979 Sep; 10(3):69-70, 77. PubMed ID: 298704
    [No Abstract]   [Full Text] [Related]  

  • 6. [Total activity and profile of lactic dehydrogenase isoenzymes in the serum of patients with chronic renal failure].
    Markiewicz K; Kubasiewicz-Ujma B; Lutz W
    Pol Tyg Lek; 1972 Jan; 27(5):172-4. PubMed ID: 5010761
    [No Abstract]   [Full Text] [Related]  

  • 7. [Behavior of some enzyme activities in the lymphocytes of the uremic patient].
    Esposito R; Del Vecchio Blanco C; Budillon G; Landolfi M; Papa A; Giordano C
    Minerva Nefrol; 1972; 19(3):185-6. PubMed ID: 4681092
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of sevelamer hydrochloride on serum concentration of whole (1-84) and N-terminally truncated (7-84) parathyroid hormone fragments in hemodialysis uremic patients.
    Chudek J; Piecha G; Kokot F; Wiecek A
    J Nephrol; 2003; 16(5):710-5. PubMed ID: 14733418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hemodialysis on the inhibition of nervous tissue transketolase and on uremic neuropathy.
    Sterzel RB; Semar M; Lonergan ET; Lange K
    Trans Am Soc Artif Intern Organs; 1971; 17():77-9. PubMed ID: 5158138
    [No Abstract]   [Full Text] [Related]  

  • 10. [Significance of peptides in the molecular etiology of uremic toxemia].
    Menyhárt J; Gróf J
    Orv Hetil; 1979 Jul; 120(30):1795-801. PubMed ID: 471491
    [No Abstract]   [Full Text] [Related]  

  • 11. Creatine phosphokinase in long-term dialysis patients.
    Soffer O; Fellner SK; Rush RL
    Arch Intern Med; 1981 Feb; 141(2):181-8. PubMed ID: 7458513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Total activity and profile of serum lactic dehydrogenase isoenzymes in patients with nephrotic syndrome].
    Markiewicz K; Kubasiewicz-Ujma B; Lutz W
    Pol Tyg Lek; 1972 Feb; 27(7):259-62. PubMed ID: 5011602
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparison of 2 technics for the determination of multimolecular forms of lactic dehydrogenase].
    Plomteux G
    Ann Biol Clin (Paris); 1970; 28(2):131-5. PubMed ID: 5450913
    [No Abstract]   [Full Text] [Related]  

  • 14. Uremic middle molecules.
    Bergström J; Fürst P
    Clin Nephrol; 1976 Apr; 5(4):143-52. PubMed ID: 1277596
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of transepithelial sodium transport in the frog skin by a low molecular weight fraction of uremic serum.
    Bourgoignie J; Klahr S; Bricker NS
    J Clin Invest; 1971 Feb; 50(2):303-11. PubMed ID: 5540168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale for the use of a low molecular weight heparin during hemodialysis with polysulphone membrane in uremic patients.
    Moia M; Graziani G; Tenconi PM; Martinelli I; Ponticelli C
    Ann Ital Med Int; 1997; 12(2):67-71. PubMed ID: 9284597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blood folates in chronic uremic patients in dialysis treatment].
    Chelazzi G; Bernasconi G; Gastaldi L; Martegani M; Fachinetti A; Giuliani F
    Minerva Med; 1980 Oct; 71(42):3073-86. PubMed ID: 7022266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes of the isoenzymes with lactic dehydrogenase activity and of other serum enzymes in myocardial infarct].
    Bonera E; Cavaliere G; Albertini A
    Cardiol Prat; 1968 Feb; 19(1):33-7. PubMed ID: 5685526
    [No Abstract]   [Full Text] [Related]  

  • 19. [Serum levels of medium-sized molecules in children with chronic kidney failure under conditions of short-term hemodialysis].
    Scigalla P; Gudim VI; Noack C; Devaux S; Grossmann P
    Z Urol Nephrol; 1980 Dec; 73(12):915-22. PubMed ID: 7223091
    [No Abstract]   [Full Text] [Related]  

  • 20. [The alpha-1-acid glycoprotein (alpha-1-ag) in serum of uremic patients in maintenance hemodialysis].
    Docci D; Cenciotti L; Turci F; Salvi G
    Quad Sclavo Diagn; 1982 Dec; 18(4):416-21. PubMed ID: 7186645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.